AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor. It is part of the AM series of cannabinoids discovered by Alexandros Makriyannis at Northeastern University.
| Attributes | Values |
|---|---|
| rdfs:comment |
|
| rdfs:seeAlso | |
| foaf:depiction | |
| CAS number |
|
| IUPAC name |
|
| thumbnail |